Advanced search
Publication Cover
Infectious Diseases Volume 49, 2017 - Issue 1
Submit an article Journal homepage
582
Views
21
CrossRef citations to date
0
Altmetric
Review article

Antiretroviral treatment for HIV infection: Swedish recommendations 2016

Jaran EriksenDepartment of Clinical Pharmacology, Karolinska University Hospital and Division of Clinical Pharmacology and Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Correspondence[email protected]
,
Jan AlbertDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet and Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden;
,
Anders BlaxhultVenhälsan, Södersjukhuset and The Swedish Agency for Public Health, Stockholm, Sweden;
,
Christina CarlanderClinic of Infectious Diseases, Västmanland County Hospital, Västerås, Sweden;
,
Leo FlamholcDepartment of Infectious Diseases, Skåne University Hospital, Malmö, Sweden;
,
Magnus GisslénDepartment of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Sweden;
,
Filip JosephsonThe Swedish Medical Products Agency, Uppsala, Sweden;
,
Olof KarlströmThe Swedish Medical Products Agency, Uppsala and Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden;
,
Lars NavérDivision of Pediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet and Department of Pediatrics, Karolinska University Hospital, Stockholm, Sweden;
,
Veronica SvedhemDepartment of Infectious Diseases, Karolinska University Hospital and Division of Infectious Diseases and Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden;
,
Aylin YilmazDepartment of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Sweden;
&
Anders SönnerborgDivision of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; All members of the Swedish Reference Group for Antiviral Therapy
 show all
Pages 1-34 | Received 25 Aug 2016, Accepted 05 Oct 2016, Published online: 02 Nov 2016

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (13)

Ewa Carlsson-Lalloo, Marie Rusner, Marie Berg, Veronica Svedhem & Åsa Mellgren. (2022) People living with HIV in Sweden report high levels of sexual satisfaction in a registry-based cohort study. AIDS Care 34:5, pages 559-567.
Read now
Jaran Eriksen, Christina Carlander, Jan Albert, Leo Flamholc, Magnus Gisslén, Lars Navér, Veronica Svedhem, Aylin Yilmaz & Anders Sönnerborg. (2020) Antiretroviral treatment for HIV infection: Swedish recommendations 2019. Infectious Diseases 52:5, pages 295-329.
Read now
Aylin Yilmaz, Åsa Mellgren, Dietmar Fuchs, Staffan Nilsson, Kaj Blennow, Henrik Zetterberg & Magnus Gisslén. (2019) Switching from a regimen containing abacavir/lamivudine or emtricitabine/tenofovir disoproxil fumarate to emtricitabine/tenofovir alafenamide fumarate does not affect central nervous system HIV-1 infection. Infectious Diseases 51:11-12, pages 838-846.
Read now
Stefano Nicolè, Massimiliano Lanzafame, Emanuela Lattuada, Dora Luise, Marta Vecchi, Evelina Tacconelli & Sandro Vento. (2019) Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients. Infectious Diseases 51:8, pages 615-617.
Read now
Justyna D. Kowalska, Jolanta Popielska, Agnieszka Wroblewska, Ewa Firląg-Burkacka, Andrzej Horban & Magdalena Marczyńska. (2019) Both improvement and worsening of adherence to antiretroviral treatment can be expected while transitioning HIV-positive adolescents to adult health care. Infectious Diseases 51:6, pages 463-466.
Read now
Filippo Del Puente, Niccolo’ Riccardi, Lucia Taramasso, Alberto Borghetti, Alessandro D’Avino, Sara Irene Bonelli, Andrea De Luca, Maurizio Zazzi & Antonio Di Biagio. (2019) Is it time to re-think the use of etravirine in patients with available genotypic resistance test?. Infectious Diseases 51:6, pages 452-455.
Read now
Massimiliano Lanzafame, Sebastiano Rizzardo, Daniela Piacentini, Emanuela Lattuada, Sheila Chiesi & Sandro Vento. (2019) Dolutegravir monotherapy: an option for highly adherent HIV1-infected naive patients with relatively low zenith HIV-RNA?. Infectious Diseases 51:1, pages 77-78.
Read now
V. V. Ramalingam, J. P. Demosthenes, B. C. Ghale, P. Rupali, G. M. Varghese, O. C. Abraham & R. Kannangai. (2019) Frequency of cross-resistance to rilpivirine and etravirine among HIV-1 subtype C infected individuals failing nevirapine/efavirenz based ART regimen. Infectious Diseases 51:1, pages 71-74.
Read now
Massimiliano Lanzafame, Daniela Piacentini, Emanuela Lattuada, Sebastiano Rizzardo, Sheila Chiesi & Sandro Vento. (2018) “High” antiretroviral deintensification, a strategy to avoid drug interactions and unfavourable long-term effects of HAART. Infectious Diseases 50:10, pages 788-790.
Read now
Lars Navér, Jan Albert, Christina Carlander, Leo Flamholc, Magnus Gisslén, Olof Karlström, Veronica Svedhem-Johansson, Anders Sönnerborg, Katarina Westling, Aylin Yilmaz & Karin Pettersson. (2018) Prophylaxis and treatment of HIV-1 infection in pregnancy – Swedish Recommendations 2017. Infectious Diseases 50:7, pages 495-506.
Read now
Leonardo Calza, Matteo Cafaggi, Vincenzo Colangeli, Marco Borderi, Enrico Barchi, Massimiliano Lanzafame, Stefano Nicole’, Anna Maria Degli Antoni, Isabella Bon, Maria Carla Re & Pierluigi Viale. (2018) Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy. Infectious Diseases 50:5, pages 352-360.
Read now
Laura Galli, Andrea Poli, Camilla Muccini, Nadia Galizzi, Anna Danise, Vincenzo Spagnuolo, Nicola Gianotti, Elisabetta Carini, Adriano Lazzarin & Antonella Castagna. (2018) An observational, retrospective analysis evaluating switching to raltegravir plus abacavir/lamivudine in HIV-1-infected patients: the ORASWIRAL study. Infectious Diseases 50:3, pages 220-222.
Read now
Shinichi Hikasa, Kyoko Hideta, Shota Shimabukuro, Satoshi Higasa, Akihiro Sawada, Tazuko Tokugawa & Takeshi Kimura. (2018) Utility of estimated glomerular filtration rate based on cystatin C in patients receiving combination antiretroviral therapy including dolutegravir. Infectious Diseases 50:1, pages 77-79.
Read now

Articles from other publishers (8)

Åsa Mellgren, Lars E. Eriksson, Maria Reinius, Gaetano Marrone & Veronica Svedhem. (2020) Longitudinal trends and determinants of patient-reported side effects on ART–a Swedish national registry study. PLOS ONE 15:12, pages e0242710.
Crossref
Brian R. Wood. (2020) Tenofovir alafenamide versus tenofovir disoproxil fumarate: integrating systematic review findings into practice and policy. AIDS 34:15, pages 2319-2320.
Crossref
Allahna Esber, Christina Polyak, Francis Kiweewa, Jonah Maswai, John Owuoth, Lucas Maganga, Yakubu Adamu, Patrick W Hickey, Julie A Ake & Trevor A Crowell. (2019) Persistent Low-level Viremia Predicts Subsequent Virologic Failure: Is It Time to Change the Third 90?. Clinical Infectious Diseases 69:5, pages 805-812.
Crossref
Erik De Clercq. (2018) Role of tenofovir alafenamide (TAF) in the treatment and prophylaxis of HIV and HBV infections. Biochemical Pharmacology 153, pages 2-11.
Crossref
Erik Sörstedt, Christina Carlander, Leo Flamholc, Bo Hejdeman, Veronica Svedhem, Anders Sönnerborg, Magnus Gisslén & Aylin Yilmaz. (2018) Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations. International Journal of Antimicrobial Agents 51:5, pages 733-738.
Crossref
C Carlander, G Marrone, J Brännström, A Yilmaz, K Elfgren, P Sparén & A Sönnerborg. (2017) Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study. BJOG: An International Journal of Obstetrics & Gynaecology 124:11, pages 1680-1687.
Crossref
Olof Elvstam, Patrik Medstrand, Aylin Yilmaz, Per-Erik Isberg, Magnus Gisslén & Per Björkman. (2017) Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment. PLOS ONE 12:7, pages e0180761.
Crossref
Amanda Häggblom, Stefan Lindbäck, Magnus Gisslén, Leo Flamholc, Bo Hejdeman, Andreas Palmborg, Amy Leval, Eva Herweijer, Sverrir Valgardsson & Veronica Svedhem. (2017) HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014. PLOS ONE 12:2, pages e0171227.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.